SUPPLY AGREEMENTSupply Agreement • May 12th, 2016 • ChromaDex Corp. • Medicinal chemicals & botanical products • California
Contract Type FiledMay 12th, 2016 Company Industry JurisdictionTHIS SUPPLY AGREEMENT (the "Agreement"), is made and entered into as of June 26, 2014 (the “Effective Date”) by and between Elysium Health, LLC, a Florida limited liability corporation having a place of business at 200 Congress Park Drive, Suite 205, Delray Beach, FL 33445 and ChromaDex Inc., a California corporation with principal offices located at 10005 Muirlands, Blvd, Suite G, Irvine, CA 92618, USA.
FIRST AMENDMENT TO NIAGEN(R) SUPPLY AGREEMENTNiagen(r) Supply Agreement • May 12th, 2016 • ChromaDex Corp. • Medicinal chemicals & botanical products
Contract Type FiledMay 12th, 2016 Company IndustryTHIS AMENDMENT is entered into this 31st day of March 2015 (the “Effective Date” of the First Amendment), by and between 5Linx Enterprises, Inc., with principal offices located at 275 Kenneth Drive, Rochester, NY 14623 (“Buyer”) and ChromaDex, Inc., with principals offices located at 10005 Muirlands Blvd., Suite G, Irvine, CA 92618 (“Seller”).
SECOND AMENDMENT TO NIAGEN(R) SUPPLY AGREEMENTNiagen(r) Supply Agreement • May 12th, 2016 • ChromaDex Corp. • Medicinal chemicals & botanical products
Contract Type FiledMay 12th, 2016 Company IndustryTHIS SECOND AMENDMENT is effective and binding as of the last date of signing of this Second Amendment (the “Effective Date of the Second Amendment”), by and between 5Linx Enterprises, Inc., with principal offices located at 275 Kenneth Drive, Rochester, NY 14623 (“Buyer”) and ChromaDex, Inc., with principals offices located at 10005 Muirlands Blvd., Suite G, Irvine, CA 92618 (“Seller”).
ADDENDUM TO THE NIAGEN(TM) SUPPLY AGREEMENT BETWEEN 5LINX ENTERPRISES, INC. AND CHROMADEX, INC.Niagen Supply Agreement • May 12th, 2016 • ChromaDex Corp. • Medicinal chemicals & botanical products
Contract Type FiledMay 12th, 2016 Company IndustryThis Addendum (the “Addendum”) dated June 26, 2014 (“Addendum Effective Date”), is attached to and forms part of the NIAGEN SUPPLY AGREEMENT (the “Agreement”) dated January 3, 2014 made by and between ChromaDex, Inc., a California corporation, having a principal place of business at 10005 Muirlands Blvd, Suite G, Irvine, CA 92618 (“Seller”) and 5Linx Enterprises, Inc., a Delaware Corporation with principal offices located at 275 Kenneth Drive, Rochester, NY 14623 (“Buyer”). To the extent that any of the terms or conditions contained in this Addendum may contradict or conflict with any of the terms or conditions of the Agreement, it is expressly understood and agreed that the terms of this Addendum shall take precedence and supersede the Agreement.
SUPPLY AGREEMENTSupply Agreement • May 12th, 2016 • ChromaDex Corp. • Medicinal chemicals & botanical products • California
Contract Type FiledMay 12th, 2016 Company Industry JurisdictionTHIS SUPPLY AGREEMENT (this “Agreement”) is entered into as of February 3rd, 2014 (the “Effective Date”), between ChromaDex, Inc., a California corporation (“ChromaDex”), having a place of business at 10005 Muirlands Blvd., Suite G, Irvine, CA 92618, and Elysium Health, LLC, a Florida limited liability corporation (“Elysium Health”), having a place of business at 200 Congress Park Drive, Suite 205, Delray Beach, FL 33445.